Japan Precision Medicine Business Opportunities Databook - Q2 2023 Update

According to the publisher, Japan precision medicine market size is expected to record a CAGR of 13.4% during 2023-2027 to reach US$7.753 billion by 2027, increasing from US$4.644 billion in 2023. Over the last five years, the sector has recorded a CAGR of 12.2% to reach US$4.138 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in the precision medicine industry. It covers a detailed view of market size and forecast across various segments such as by category, technology platform, by technology, by gene sequencing technology, by drugs, by route of administration, by application, and by end users.

This section is a part of the title “Global Precision Medicine Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape - Q2 2023 Update”.

Scope

This report provides an in-depth, data-centric analysis of the Japan precision medicine market 2018-2027. Below is a summary of key market segments:

Precision medicine market share by category

• Diagnostics
• Therapeutics
• Others

Precision medicine market share by technology platform

• Cloud Based
• On-Premises

Precision medicine market share by technology

• Bioinformatics
• Big Data Analytics
• Drug Discovery
• Companion Diagnostics
• Gene Sequencing
• Others

Precision medicine market share by sequencing technology

• Chain Termination Sequencing
• Nanopore Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Ion Semiconductor Sequencing
• Single Molecule Real Time Sequencing
• Sequencing by Synthesis

Precision medicine market share by drugs

• Mepolizumab
• Osimertinib
• Aripiprazole Lauroxil
• Alectinib
• Others

Precision medicine market share by route of administration

• Injectable
• Oral
• Others

Precision medicine market share by application

• Oncology
• CNS
• Cardiovascular
• Infectious Diseases
• Others

Precision medicine market share by end user

• Pharmaceuticals and Biotechnology Companies
• Diagnostics Companies
• Healthcare IT Specialists/Big Data Companies
• Clinical Laboratories

Reasons to buy

• In-depth understanding of precision medicine market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in Japan.
• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
• Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceuticals and biotechnology companies, diagnostics companies, healthcare IT specialists/big data companies, clinical laboratories within the Japan.